US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beta Bionics, Inc.

10.05

-1.0900-9.78%

Volume:291.91K

Turnover:2.99M

Market Cap:435.66M

PE:-1.17

High:11.06

Open:11.06

Low:10.04

Close:11.14

Loading ...

Overview Company News Filings

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

Beta Bionics to Host Investor Event on June 22, 2025

Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus

Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration

Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration

Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans

Beta Bionics Appoints Gerard Michel as Director

Press Release: Beta Bionics Announces Board Appointment of Gerard Michel

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)

Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance

MT Newswires Live

Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate

Beta Bionics Inc Outlook 2025 Total Revenue of Approximately $80 Mln to $85 Mln

THOMSON REUTERS

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal

BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating

Beta Bionics initiated with a Buy at BofA

BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":10.05,"timestamp":1745265600000,"preClose":11.14,"halted":0,"volume":291905,"delay":0,"floatShares":35572413,"shares":43348840,"eps":-8.602584,"marketStatus":"Pre-Mkt","change":-1.09,"latestTime":"04-22 07:47:35 EDT","open":11.06,"high":11.06,"low":10.04,"amount":2991806.0912,"amplitude":0.091562,"askPrice":11.46,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.602584,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":10.05,"postHourTrading":{"tag":"盘后","latestPrice":10.05,"preClose":10.05,"latestTime":"16:05 EDT","volume":288,"amount":2894.4,"timestamp":1745265911740},"volumeRatio":0.8583416498223541},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":35572413,"roa":"-21.78%","roe":"-81.35%","lyrEps":-8.602584,"volumeRatio":0.8583416498223541,"shares":43348840,"dividePrice":0,"high":11.06,"amplitude":0.091562,"preClose":11.14,"low":10.04,"week52Low":8.89,"pbRate":"-1.78","psRate":"6.69","week52High":24.5,"institutionHeld":0,"latestPrice":10.05,"eps":-8.602584,"divideRate":0,"volume":291905,"delay":0,"ttmEps":-8.602584,"open":11.06,"prevYearClose":17,"prevWeekClose":11.14,"prevMonthClose":12.24,"prevQuarterClose":12.24,"fiveDayClose":10.91,"twentyDayClose":15.1,"sixtyDayClose":17,"earningDate":1746460800000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528205097","title":"Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528205097","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528205097?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April 16, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 financial results after the financial markets close on Tuesday, May 6, 2025. In connection with the release, management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time .Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announce-first-quarter-200500089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2526508143","title":"Beta Bionics to Host Investor Event on June 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526508143","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526508143?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:30","pubTimestamp":1744198200,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April  09, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058311/0/en/Beta-Bionics-to-Host-Investor-Event-on-June-22-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4181","BK4082","BK4218","HST","BBNX","BK4585"],"gpt_icon":0},{"id":"2524208041","title":"Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208041?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:16","pubTimestamp":1743765373,"startTime":"0","endTime":"0","summary":"In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4127","BBNX","BK4082"],"gpt_icon":0},{"id":"1143484942","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1143484942","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143484942?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a positive analyst report from Bank of America Securities. Analyst Travis Steed reiterated a Buy rating on the stock, signaling continued confidence in the company's growth prospects.Beta Bionics, known for its innovative medical technologies, has been gaining attention from investors and analysts alike. The company's strategic expansion plans and potential market opportunities appear to be driving the optim","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"1100546963","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1100546963","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100546963?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a bullish analyst report from Bank of America Securities. The stock's significant uptick comes after analyst Travis Steed reiterated a Buy rating on BBNX, highlighting the company as an undervalued growth opportunity.In the report released early Monday, Steed emphasized Beta Bionics' strategic expansion plans as a key factor in his positive outlook. While specific details of the report were not immediately a","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2523910757","title":"Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910757?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:15","pubTimestamp":1743419733,"startTime":"0","endTime":"0","summary":"In a report released today, Travis Steed from Bank of America Securities reiterated a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683348.USD","LU0130103400.USD","LU0098860793.USD","LU1074936037.SGD","LU1496350171.SGD","LU0070302665.USD","LU1718418525.SGD","BBNX","LU0128525689.USD","LU0417517546.SGD","LU0321505439.SGD","LU0320765646.SGD","LU1894683264.USD","LU2129689431.USD","LU0130102774.USD","LU0787776722.HKD","LU0170899867.USD","BK4581","LU1162221912.USD","LU1363072403.SGD","LU0234572021.USD","LU2133065610.SGD","LU0648001328.SGD","LU1496350502.SGD","LU1880398554.USD","LU0868494617.USD","LU0052756011.USD","LU1280957306.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","IE00BLSP4239.USD","LU1267930227.SGD","BK4585","IE00B1BXHZ80.USD","LU0310800965.SGD","LU0306807586.USD","LU1201861165.SGD","BAC","LU2129689514.USD","IE00BFXG1179.USD","LU1366192091.USD","LU0256863902.USD","LU0256863811.USD","LU0683600562.USD","LU0320765489.SGD","LU0208291251.USD","LU0314106906.USD","LU0640476718.USD","BK4588","BK4559"],"gpt_icon":0},{"id":"2522853045","title":"Beta Bionics Appoints Gerard Michel as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853045?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:18","pubTimestamp":1743110309,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) just unveiled an update. On March 26, 2025, Beta Bionics, Inc. announced the appointment of Gerard Michel as a Class...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2522534031","title":"Press Release: Beta Bionics Announces Board Appointment of Gerard Michel","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534031","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534031?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:45","pubTimestamp":1743108300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, 2025. Mr. Michel is Chief Executive Officer of Delcath Systems , a commercial-stage interventional oncology company.Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across numerous functional areas. Prior to joining Delcath Systems as Chief Executive Officer in 2020, Mr. Michel served as Chief Financial Officer at Vericel Corporation, a biopharmaceutical company. Mr. Michel also served as Chief Financial Officer and Vice President, Corporate Development at Biodel, Inc. from November 2007 to May 2014, and Chief Financial Officer and Vice President of Corporate Development at NPS Pharmaceuticals Inc. from August 2002 to November 2007. Previously, Mr. Michel was a Principal at Booz All","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2522805384","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805384?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:00","pubTimestamp":1742994009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TriSalus Life Sciences (TLSI – Research Report) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","TLSI","HCSG","BBNX","BK4082"],"gpt_icon":0},{"id":"2522061822","title":"Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522061822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522061822?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:40","pubTimestamp":1742985625,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dexcom (DXCM – Research Report), Alnylam Pharma (ALN...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALNY","LU0354030511.USD","BK4551","LU1323610961.USD","ALN","LU2125909247.SGD","LU1923622614.USD","BK4585","BK4534","BK4139","LU2211815571.USD","BK4548","IE00BMPRXR70.SGD","BK4504","DXCM","LU0354030438.USD","LU0266013472.USD","LU2433249047.HKD","LU2125909593.SGD","BBNX","BK4137","IE00BMPRXN33.USD","HCSG","BK4588","BK4082"],"gpt_icon":0},{"id":"2522915833","title":"Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2522915833","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522915833?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:50","pubTimestamp":1742935835,"startTime":"0","endTime":"0","summary":"Beta Bionics  reported a Q4 net loss late Tuesday of $2.72 per diluted share.The company did not provide a year-ago per-share figure.Analysts polled by Factset expected a loss of $0.90.Net sales for the quarter ended Dec. 31 were $20.4 million, up from $8.4 million a year earlier.Analysts surveyed by Factset expected $20.2 million.The company set full-year 2025 revenue guidance between $80 million and $85 million.Analysts polled by Factset expect $85.1 million.Beta Bionics completed its initial public offering on Jan. 30, listing on the Nasdaq Global Market.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2522887701","title":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887701","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887701?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:09","pubTimestamp":1742933340,"startTime":"0","endTime":"0","summary":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481372/beta-bionics-q4-2024-gaap-eps-2-72-beats-2-91-estimate-sales-20-400m-beat-20-187m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2522875098","title":"Beta Bionics Inc Outlook 2025 Total Revenue of Approximately $80 Mln to $85 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875098?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:02","pubTimestamp":1742932921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA672JQT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2522757838","title":"Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522757838","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522757838?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:02","pubTimestamp":1742932920,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 25, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2024 and introduced its annual guidance for the year ending December 31, 2025.Fourth Quarter 2024 Financial Highlights & Key Metrics. Net sales of $20.4 million, up 145% compared to $8.4 million in the fourth quarter of 2023.Durable Medical Equipment  channel net sales of $18.1 million, up 127% compared to $7.9 million in the fourth quarter of 2023.Pharmacy Benefit Plan  channel net sales of $2.4 million, up 491% compared to $0.4 million in the fourth quarter of 2023.Installed customer base  of 15,298 users, up 564% compared to 2,304 in the fourth quarter of 2023.4,084 new patient starts, up 125% compared to 1,818 new patient starts in the fourth quarter of 2023.70% of new patient starts came from multiple daily injections .Low-teens percentage of new patient starts reim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announces-fourth-quarter-200200338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","PBP","BBNX"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRAG","NKE","NKTX","OUST","LEN","DRI","JEF","CBUS","FBRX","DERM","IFRX","MBRX","BRNS","ASO","MGNX","MLKN","RUM","COYA","PL","TELA","SBS","SOWG","SKYE","SPRY","BCAB","BLRX","FLUX","ACRV","THRD","ALUR","CMC","CURV","TITN","BBNX","JKS","GDEV","MNSO","LVTX","MREO","KLC","CDLR","SLS","CELC","TH","LPTX","WOR","RLMD","PAYX"],"gpt_icon":1},{"id":"2514053418","title":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514053418","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514053418?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time , to review the company’s fourth quarter and full year 2024 performance.Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announce-fourth-quarter-120000112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2514097110","title":"BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097110","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097110?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493805,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL6N3PG0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRA","PYPL","YY","DNUT","NEM","MTSR","HD","NVDS.UK","NVIW.SI","SNVD.UK","CSCO","AS","CIVI","EVS.SI","CHGG","AU","ONVO","CAKE","IART","BBNX","ZM","02020","NIO.SI","NVD3.UK","KDP","3NVD.UK","CLF","DOMH","PLNT","SRE","LLY","BKSY","EVER","PTLO","NVD2.UK","HRMY"],"gpt_icon":1},{"id":"2514709525","title":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514709525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514709525?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:42","pubTimestamp":1740487363,"startTime":"0","endTime":"0","summary":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating** BofA Global Research starts coverage on insulin device maker Beta Bionics BBNX.O with \"buy\" rating and $25 PT, citing its \"differentiated closed-loop algorithm\" that simplifies insulin-dosing for diabetic patients** PT represents a 21.4% upside to stock's last close** Brokerage believes BBNX will help expand the current $2 billion U.S. insulin pump market, which has only seen 7% penetration growth in seven years** Co's iLet insulin pump's simplicity can help those taking daily insulin injections switch to a simpler way - BofA** Brokerage expects BBNX's revenue to grow by $15 mln in 2025 and $26 mln in 2026** Stock has fallen 12.8% since its Nasdaq debut on 30 Jan  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BAC"],"gpt_icon":0},{"id":"2514693772","title":"Beta Bionics initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2514693772","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514693772?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:21","pubTimestamp":1740421261,"startTime":"0","endTime":"0","summary":"BofA initiated coverage of Beta Bionics (BBNX) with a Buy rating and $25 price target Beta’s iLet insulin pump simplifies insulin-dosing for insuli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513787567","title":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2513787567","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513787567?lang=en_us&edition=fundamental","pubTime":"2025-02-24 23:34","pubTimestamp":1740411293,"startTime":"0","endTime":"0","summary":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO** Wall Street brokerages start coverage of insulin device maker, Beta Bionics BBNX.O, on a bullish note as IPO research quiet pe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF12B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","IE00B19Z3581.USD","LU0683600562.USD","LU1162221912.USD","LU1880398471.USD","LU0130518102.USD","LU0149725797.USD","LU0320765489.SGD","LU1074936037.SGD","SIVBQ","LU0417517546.SGD","LU2133065610.SGD","IE00BFXG1179.USD","LU0130103400.USD","LU1201861249.SGD","LU1894683264.USD","LU0321505868.SGD","LU0170899867.USD","BBNX","BK4559","BK4581","LU0980610538.SGD","BK4211","BK4553","LU0234572021.USD","BK4585","LU0053666078.USD","LU0306807586.USD","LU0320765646.SGD","LU0477156797.USD","IE0002270589.USD","LU0640476718.USD","LU1496350171.SGD","LU0306806265.USD","LU1267930227.SGD","BK4589","LU0648000940.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1366192091.USD","BK4207","LU0971096721.USD","BK4504","LU1894683348.USD","LU2129689605.HKD","LU1718418525.SGD","LU0787776722.HKD","IE00BZ1G4Q59.USD","BAC","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2025-05-06","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"defaultRemindTime":1746561600000,"name":null,"time":"Post Market","dateTimestamp":1746504000000,"actualEps":null},{"market":"US","date":"2025-03-25","symbol":"BBNX","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.2857,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1740628800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2025-04-21","current":-8.819236,"percent":0.821429,"low":-18.401318,"twenty":-16.843777,"median":-12.221585,"eighty":-8.97282,"high":-3.90273,"avg":-12.871764,"sd":3.649053,"marketCap":482906077},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-21","current":-8.819236,"twenty":-16.843777,"median":-12.221585,"eighty":-8.97282,"marketCap":482906077}],"updateTime":1745322455375}}}